Intermede Investment Partners LTD West Pharmaceutical Services Inc Transaction History

Intermede Investment Partners LTD

$4.79 Billion
Q3 2024

A detailed history of Intermede Investment Partners LTD transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Intermede Investment Partners LTD holds 249,185 shares of WST stock, worth $82.9 Million. This represents 1.56% of its overall portfolio holdings.

Number of Shares

249,185

Previous 195,334 27.57%

Holding current value

$82.9 Million

Previous $64.3 Million 16.25%

% of portfolio

1.56%

Previous 1.36%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$277.16 - $333.3 $14.9 Million - $17.9 Million	53,851 Added 27.57%	249,185 $74.8 Million
Q2 2024 Jul 17, 2024	SELL	$314.68 - $395.94 $16.6 Million - $20.9 Million	-52,739 Reduced 21.26%	195,334 $64.3 Million
Q1 2024 May 10, 2024	BUY	$338.27 - $413.0 $14.4 Million - $17.6 Million	42,536 Added 20.7%	248,073 $98.2 Million
Q4 2023 Feb 12, 2024	SELL	$318.29 - $392.21 $3.2 Million - $3.95 Million	-10,061 Reduced 4.67%	205,537 $72.4 Million
Q3 2023 Nov 08, 2023	SELL	$354.9 - $412.41 $20.5 Million - $23.8 Million	-57,699 Reduced 21.11%	215,598 $80.9 Million
Q2 2023 Aug 09, 2023	SELL	$334.63 - $382.47 $21.5 Million - $24.6 Million	-64,268 Reduced 19.04%	273,297 $105 Million
Q1 2023 May 15, 2023	BUY	$232.5 - $346.47 $328,987 - $490,255	1,415 Added 0.42%	337,565 $117 Million
Q4 2022 Feb 09, 2023	BUY	$209.34 - $261.61 $14.9 Million - $18.6 Million	71,005 Added 26.78%	336,150 $79.1 Million
Q3 2022 Oct 24, 2022	BUY	$246.08 - $343.65 $3.21 Million - $4.48 Million	13,027 Added 5.17%	265,145 $65.2 Million
Q2 2022 Aug 03, 2022	BUY	$280.61 - $420.45 $2.05 Million - $3.08 Million	7,314 Added 2.99%	252,118 $76.2 Million
Q1 2022 Apr 28, 2022	BUY	$357.49 - $445.92 $6.01 Million - $7.49 Million	16,805 Added 7.37%	244,804 $101 Million
Q4 2021 Jan 14, 2022	BUY	$402.25 - $471.34 $2.84 Million - $3.32 Million	7,048 Added 3.19%	227,999 $107 Million
Q3 2021 Oct 27, 2021	SELL	$363.01 - $468.47 $700,972 - $904,615	-1,931 Reduced 0.87%	220,951 $93.8 Million
Q2 2021 Jul 30, 2021	SELL	$284.77 - $363.2 $1.31 Million - $1.67 Million	-4,605 Reduced 2.02%	222,882 $80 Million
Q1 2021 May 07, 2021	SELL	$257.29 - $307.53 $5.35 Million - $6.4 Million	-20,800 Reduced 8.38%	227,487 $64.1 Million
Q4 2020 Feb 05, 2021	BUY	$261.16 - $301.66 $12.7 Million - $14.7 Million	48,783 Added 24.45%	248,287 $70.3 Million
Q3 2020 Oct 29, 2020	SELL	$224.99 - $288.02 $3.77 Million - $4.83 Million	-16,772 Reduced 7.75%	199,504 $54.8 Million
Q2 2020 Aug 06, 2020	SELL	$149.8 - $227.17 $4.82 Million - $7.31 Million	-32,185 Reduced 12.95%	216,276 $49.1 Million
Q1 2020 May 11, 2020	SELL	$128.96 - $174.76 $542,147 - $734,691	-4,204 Reduced 1.66%	248,461 $37.8 Million
Q4 2019 Feb 10, 2020	SELL	$137.6 - $151.21 $5.87 Million - $6.46 Million	-42,691 Reduced 14.45%	252,665 $38 Million
Q3 2019 Nov 01, 2019	SELL	$121.41 - $150.02 $435,133 - $537,671	-3,584 Reduced 1.2%	295,356 $41.9 Million
Q2 2019 Jul 30, 2019	SELL	$111.27 - $125.15 $450,754 - $506,982	-4,051 Reduced 1.34%	298,940 $37.4 Million
Q1 2019 May 01, 2019	BUY	$94.53 - $110.2 $3.45 Million - $4.02 Million	36,520 Added 13.71%	302,991 $33.4 Million
Q4 2018 Feb 14, 2019	BUY	$93.0 - $123.98 $1.25 Million - $1.66 Million	13,400 Added 5.29%	266,471 $26.1 Million
Q3 2018 Oct 29, 2018	BUY	$98.01 - $123.47 $987,744 - $1.24 Million	10,078 Added 4.15%	253,071 $31.2 Million
Q2 2018 Aug 08, 2018	SELL	$83.32 - $101.88 $684,473 - $836,944	-8,215 Reduced 3.27%	242,993 $24.1 Million
Q1 2018 May 01, 2018	BUY	$85.56 - $102.4 $21.5 Million - $25.7 Million	251,208 New	251,208 $22.2 Million

Others Institutions Holding WST

# of Institutions

802

Shares Held

64.3M

Call Options Held

294K

Put Options Held

490K

View Full List

About WEST PHARMACEUTICAL SERVICES INC

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $24.6B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

More about WST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intermede Investment Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Intermede Investment Partners LTD with notifications on news.

Account

Intermede Investment Partners LTD West Pharmaceutical Services Inc Transaction History